Albiruni Ryan Abdul Razak, MB BCh, BM BCh

Princess Margaret Cancer Center
Toronto, Ontario, Canada

Disclosure information not submitted.

Presentation(s):

• Paper 09 - MULTISCALE TRANSCRIPTOMICS REVEALS THE OVERARCHING LANDSCAPE OF MESENCHYMAL NEOPLASMS AND BIOLOGICALLY MEANINGFUL SUBTYPES

  Thursday, November 2, 2023
  11:00 AM - 12:30 PM  

• Paper 24 - MILADEMETAN VS. TRABECTEDIN IN PATIENTS WITH DEDIFFERENTIATED LIPOSARCOMA: RESULTS FROM THE PHASE 3 MANTRA STUDY

  Thursday, November 2, 2023
  4:00 PM - 5:30 PM  

• Paper 27 - SAFETY AND EFFICACY UPDATES FROM A PHASE 1 STUDY OF VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR

  Thursday, November 2, 2023
  4:00 PM - 5:30 PM  

• Paper 30 - OUTCOMES OF PATIENTS WITH ADVANCED SYNOVIAL SARCOMA TREATED WITH AFAMITRESGENE AUTOLEUCEL ("AFAMI-CEL")

  Friday, November 3, 2023
  9:00 AM - 10:00 AM  

• Paper 34 - A PHASE II STUDY OF DURVALUMAB AND TREMELIMUMAB IN PATIENTS WITH ADVANCED OSTEOSARCOMA AND UNDIFFERENTIATED PLEOMORPHIC SARCOMA

  Friday, November 3, 2023
  9:00 AM - 10:00 AM  

• Paper 52 - REAL-WORD EXPERIENCE OF SORAFENIB AND PAZOPANIB IN PATIENTS WITH DESMOID TUMORS: A CANSARCC STUDY

  Friday, November 3, 2023
  2:30 PM - 4:00 PM  

• Paper 80 - THE PET-RPS STUDY: A PROSPECTIVE EVALUATION OF PET-MR IN PREDICTING RESPONSE TO PREOPERATIVE CHEMOTHERAPY FOR PRIMARY RETROPERITONEAL SARCOMA (RPS)

  Saturday, November 4, 2023
  2:00 PM - 3:00 PM